Background illustration for clinical trials search

Paid Clinical Trials Ogden

Discover 1,094 paid clinical trials in Ogden, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

Crohn's Disease and Ulcerative Colitis Studies for Adults With Hard-to-Treat Symptoms

for
Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative
Location: Ogden UT, Monroe NC

Sex: All

Age: 18 - 70+

Recruiting
FeaturedActive & Responsive

Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin

for
Diabetes Mellitus, Type 2, Obesity
Location: West Jordan UT, Meridian ID, Englewood CO,

Sex: All

Age: 18 - 70+

Recruiting
FeaturedActive & Responsive

Weight Loss Studies for Adults With a BMI of 27+, Including People Managing Type 2 Diabetes or Sleep Apnea

for
Obesity, Overweight, Diabetes Mellitus, Type 2,
Location: West Jordan UT, Meridian ID, Englewood CO,

Sex: All

Age: 18+

Recruiting
FeaturedActive & Responsive

Fatty Liver Disease (MASH/NASH) Studies for Adults Also Managing Diabetes, High Blood Pressure, or High Cholesterol

for
Non-alcoholic Fatty Liver Disease
Location: West Jordan UT, Albuquerque NM, Spokane WA, Van Nuys CA,

Sex: All

Age: 18 - 70+

Recruiting
FeaturedActive & Responsive

Cardiovascular Disease Studies for Adults With High Blood Pressure, High Cholesterol, AFib, or Heart Failure

for
Cardiovascular Diseases, Heart Failure, Atrial Fibrillation,
Location: West Jordan UT, Englewood CO, San Bernardino CA,

Sex: All

Age: 18+

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

for
Ulcerative Colitis
Location: Ogden UT, Colorado Springs CO, Scottsdale AZ,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07186101

Phase 2, Recruiting
Active & Responsive

Study of DONQ52 in Active Celiac Disease

for
Celiac Disease
Location: Ogden UT, West Jordan UT, Sandy City UT, Denver CO,
Sponsor: Chugai Pharmaceutical

Sex: All

Age: 18 - 70+

Code: NCT07239336

Phase 2, Recruiting
Active & Responsive

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Location: Ogden UT, Houston TX, New Iberia LA, St. Petersburg FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07165028

Phase 3, Recruiting
Active & Responsive

Evaluation of Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center Registry

for
Otitis Media With Effusion, Acute Otitis Media, Otitis Media
Location: Ogden UT, Provo UT, Louisville KY, Cherry Hill NJ,
Sponsor: Smith & Nephew, Inc.

Sex: All

Age: 0 - 17

Code: NCT05915078

Recruiting
Active & Responsive

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

for
Migraine
Location: Ogden UT, Aurora CO, Flagstaff AZ, Reno NV, Phoenix AZ,
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70

Code: NCT06972056

Phase 4, Recruiting
Active & Responsive

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

for
Irritable Bowel Syndrome
Location: Ogden UT, Idaho Falls ID, Castle Rock CO, Henderson NV,
Sponsor: Dynogen Pharmaceuticals

Sex: Female

Age: 18 - 65

Code: NCT00547469

Phase 2, Phase 3, Recruiting
Active & Responsive

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

for
Depressive Disorder, Major
Location: Clinton UT, Las Vegas NV, Orange CA, Moorpark CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07412756

Phase 3, Recruiting
Active & Responsive

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

for
Cardiovascular Disease
Location: Layton UT, Meridian ID, Littleton CO,
Sponsor: Amgen

Sex: All

Age: 50 - 70+

Code: NCT07136012

Phase 3, Recruiting
Active & Responsive

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

for
Obesity, Overweight
Location: Layton UT, Bountiful UT, Meridian ID, St. George UT,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07684235

Phase 3, Recruiting
Active & Responsive

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

for
Overweight , Obesity, Adults
Location: South Jordan UT, Sun City AZ, Tempe AZ, Oceanside CA,
Sponsor: Alveus Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07837973

Phase 2, Recruiting
Active & Responsive

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

for
Psoriasis, Overweight or Obesity
Location: Layton UT, Reno NV, Phoenix AZ, Fremont CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06857942

Phase 4, Recruiting
Active & Responsive

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

for
Advanced Esophageal Adenocarcinoma,
Location: Farmington UT, Salt Lake City UT, Boise ID, Nampa ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06203600

Phase 2, Phase 3, Recruiting
Active & Responsive

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

for
Sjögren, Sjogren Disease, Sjogren's Syndrome
Location: Salt Lake City UT, Plano TX, Webster TX, Memphis TN,
Sponsor: Cullinan Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07041099

Phase 1, Recruiting
Active & Responsive

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

for
Relapsed/Refractory Multiple Myeloma
Location: Salt Lake City UT, Aurora CO, Dallas TX, Milwaukee WI,
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05722418

Phase 1, Recruiting
Active & Responsive

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Location: Salt Lake City UT, South Jordan UT, Bozeman MT,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07198074

Phase 3, Recruiting